Bioventus Inc.
BVS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001665988
No open-market purchases or sales by Bioventus Inc. insiders were filed in the last 90 days; 156 institutions reported holding it in 13F filings for Q2 2026, worth $509.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Bioventus Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 85
- −8 vs. Q3 2022
- Shares held
- 31.4M
- −2.23M (−6.6%) vs. Q3 2022
- Total value
- $81.9M
- −$153.6M (−65.2%) vs. Q3 2022
- New holders
- 24
- 22 more added
- Sold out
- 32
- 28 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $509.4M |
| Q1 2026 | 157 | $466.4M |
| Q4 2025 | 148 | $373.3M |
| Q3 2025 | 135 | $328.9M |
| Q2 2025 | 134 | $320.3M |
| Q1 2025 | 144 | $427.0M |
| Q4 2024 | 151 | $477.8M |
| Q3 2024 | 138 | $537.1M |
| Q2 2024 | 103 | $222.2M |
| Q1 2024 | 84 | $178.0M |
| Q4 2023 | 80 | $175.4M |
| Q3 2023 | 67 | $108.9M |
| Q2 2023 | 66 | $92.6M |
| Q1 2023 | 71 | $33.4M |
| Q4 2022 | 85 | $81.9M |
| Q3 2022 | 94 | $245.9M |
| Q2 2022 | 98 | $232.0M |
| Q1 2022 | 105 | $447.0M |
| Q4 2021 | 98 | $451.6M |
| Q3 2021 | 69 | $351.8M |
| Q2 2021 | 53 | $364.5M |
| Q1 2021 | 45 | $334.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Bioventus Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MetLife Investment Management | 0 | $0 | 0.00% | −18,975−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −17,001−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −15,820−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −13,475−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −13,452−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −12,779−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −7,593−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −3,428−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −2,798−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,250−100.0% | Sold out |
| Almanack Investment Partners, LLC. | 0 | $0 | 0.00% | −1,517−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −1,432−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −577−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −154−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −173−100.0% | Sold out |
| SV Health Investors, LLC | – | – | – | – | Not filed |